SeaCrest Wealth Management’s Novavax NVAX Stock Holding History

SeaCrest Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-120	Closed	-$1K	–	1397
2019 Q1	$1K	Hold	120	–	–	﹤0.01%	2052
2018 Q4	$4K	Hold	120	–	–	﹤0.01%	1767
2018 Q3	$5K	Hold	120	–	–	﹤0.01%	1869
2018 Q2	$3K	Buy	120 +50	+71%	+$1.69K	﹤0.01%	1937
2018 Q1	$3K	Hold	70	–	–	﹤0.01%	1911
2017 Q4	$2K	Buy	+70	New	+$1.71K	﹤0.01%	2013

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SeaCrest Wealth Management's NVAX Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of Novavax (NVAX) in Q2 2019, closing a stake of 120 shares — an estimated $1K sold.

SeaCrest Wealth Management first reported a position in NVAX in Q4 2017 and held it in 6 quarters. The position peaked at $5K in Q3 2018. 81 funds tracked by Wall St. Rank hold NVAX as of Q2 2019.

SeaCrest Wealth Management reported no remaining Novavax position as of Q2 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 120 Novavax shares in Q2 2019, an estimated $1K.
SeaCrest Wealth Management first reported a position in Novavax in Q4 2017 and held it in 6 quarters.
SeaCrest Wealth Management's Novavax position peaked at $5K in Q3 2018.
81 funds tracked by Wall St. Rank held Novavax as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.